[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,154,499
  • Shares Outstanding, K 65,106
  • Annual Sales, $ 1,542 M
  • Annual Income, $ 233,560 K
  • EBIT $ 290 M
  • EBITDA $ 365 M
  • 60-Month Beta -0.06
  • Price/Sales 4.60
  • Price/Cash Flow 17.21
  • Price/Book 5.90

Options Overview Details

View History
  • Implied Volatility 59.70% (+6.81%)
  • Historical Volatility 36.97%
  • IV Percentile 73%
  • IV Rank 43.19%
  • IV High 98.35% on 11/05/25
  • IV Low 30.32% on 05/14/26
  • Expected Move (DTE 11) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 14
  • Volume Avg (30-Day) 462
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 7,786
  • Open Int (30-Day) 8,576
  • Expected Range 108.95 to 108.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.11
  • Number of Estimates 3
  • High Estimate $1.18
  • Low Estimate $1.06
  • Prior Year $1.32
  • Growth Rate Est. (year over year) -15.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
97.99 +10.89%
on 06/09/26
111.86 -2.86%
on 06/30/26
+7.68 (+7.61%)
since 06/05/26
3-Month
75.31 +44.30%
on 04/07/26
111.86 -2.86%
on 06/30/26
+32.78 (+43.19%)
since 04/06/26
52-Week
47.25 +129.98%
on 08/06/25
111.86 -2.86%
on 06/30/26
+28.25 (+35.12%)
since 07/03/25

Most Recent Stories

More News
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians...

LNTH : 107.02 (-2.61%)
Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest

Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest

LNTH : 107.02 (-2.61%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

MMSI : 70.46 (-0.89%)
LNTH : 107.02 (-2.61%)
ADUS : 104.39 (-0.74%)
1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges

1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges

VTOL : 41.75 (+0.82%)
LNTH : 107.02 (-2.61%)
PLTR : 130.56 (+0.97%)
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians...

LNTH : 107.02 (-2.61%)
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...

LNTH : 107.02 (-2.61%)
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference

BEDFORD, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians...

LNTH : 107.02 (-2.61%)
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting

BEDFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...

LNTH : 107.02 (-2.61%)
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...

LNTH : 107.02 (-2.61%)
3 Hyped Up Stocks with Warning Signs

3 Hyped Up Stocks with Warning Signs

IHRT : 4.35 (-0.68%)
LNTH : 107.02 (-2.61%)
ARRY : 7.05 (+1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

3rd Resistance Point 114.26
2nd Resistance Point 112.63
1st Resistance Point 111.26
Last Price 107.02
1st Support Level 108.26
2nd Support Level 106.63
3rd Support Level 105.26

See More

52-Week High 111.86
Last Price 107.02
Fibonacci 61.8% 87.18
Fibonacci 50% 79.56
Fibonacci 38.2% 71.93
52-Week Low 47.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.